Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.
- 1 November 1989
- Vol. 30 (Spec No) , 22-28
- https://doi.org/10.1136/gut.30.spec_no.22
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The Changing Gastrointestinal Side Effect Profile of Non-Steroidal Anti-Inflammatory Drugs: A New Approach for the Prevention of a New ProblemScandinavian Journal of Gastroenterology, 1989
- BLOOD AND PROTEIN LOSS VIA SMALL-INTESTINAL INFLAMMATION INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGSThe Lancet, 1987
- Helping the mucosa make sense of macromolecules.Gut, 1987
- Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease.The Journal of Experimental Medicine, 1987
- Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.Gut, 1986
- RHEUMATOID ARTHRITIS AND THE GUTRheumatology, 1986
- Intestinal Permeability: Clinical CorrelatesDigestive Diseases, 1986
- INTESTINAL PERMEABILITY AND INFLAMMATION IN RHEUMATOID ARTHRITIS: EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGSThe Lancet, 1984
- A PERSISTENT DEFECT IN INTESTINAL PERMEABILITY IN COELIAC DISEASE DEMONSTRATED BY A 51Cr-LABELLED EDTA ABSORPTION TESTThe Lancet, 1983
- Reactive arthritis associated with Campylobacter jejuni enteritis.BMJ, 1979